Page contents Back to list Full notification Final report General information GMO characterization European Commission administrative Information Return to search
Full notification Final report - General information Notification Number B/HU/22/02 Member State to which the notification was sent Hungary Date of acknowledgement from the Member State Competent Authority 16/08/2022 Title of the Project Multicenter Phase II trial of MB-CART2019.1 for the Treatment of Patients with relapsed/refractory DLBCL Proposed period of release: 01/12/2022 to 31/12/2025 Name of the Institute(s) or Company(ies) Miltenyi Biomedicine GmbH, Friedrich-Ebert-Stra├če 68, 51429 Bergisch Gladbach, Germany
Is the same GMO been notified elsewhere by the same notifier? Yes:
Austria; Belgium; Czech Republic; Germany; Spain; France; United Kingdom; Hungary; Italy; Lithuania; Netherlands; Poland; Sweden;
Has the same GMO been notified elsewhere by the same notifier? Yes If yes, notification number(s): B/DE/21/PEI4365; B/SE/20/003908-14 ; B/ES/21/10; B/ES/19/18; B/AT/22/01; B/SE/20/003908-14;; B/ES/21/10; B/NL/20/003; ; B/NL/20/004; GMO characterization GMO is a: Other Identity of the GMO: T cells transduced with a replication-deficient lentiviral vector harbouring the chimeric antigen receptor for targeting CD20 and CD19.  Information relating to the recipient or parental organisms from which the GMO is derived Common Name: Human Genus: Homo Species: Homo Sapiens Subspecies: Strain: Pathovar: European Commission administrative Information Consent given by the Member State Competent Authority: Not known
Select your language